Want to join the conversation?
$EL 4Q15 Q&A: Javier Escalante, Consumer Edge Research: With expansion in Sephora, is your margin degradation is going to be worse? Fabrizio Freda, CEO: As far as the expansion in Sephora, we believe this will benefit the growth in every single channel. We don’t believe this will be negative for department stores at all.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.